Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Argent Biopharma ( (AU:RGT) ) has provided an announcement.
Argent Biopharma Limited has announced the issuance of 3,333,333 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code RGT. This move is part of the company’s strategy to leverage financial instruments for growth and expansion, potentially enhancing its market position and providing value to its stakeholders.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative medical treatments. The company is primarily engaged in producing therapies for various health conditions, aiming to enhance patient outcomes and address unmet medical needs.
Average Trading Volume: 88,091
Technical Sentiment Signal: Sell
Current Market Cap: A$8.03M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.